Trending Topic

3D rendered Medical Illustration of Male Anatomy - Rectal Cancer.
14 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Gabriel Valagni, Nkafu Bechem Ndemazie, Tiago Biachi de Castria

Trifluridine/tipiracil (FTD/TPI) is a novel oral formulation of two drugs with promising results in the treatment of metastatic colorectal cancer (mCRC).1 Trifluridine is a thymidine-based nucleoside analogue that, after intracellular phosphorylation, gets incorporated into DNA, causing DNA dysfunction.2 It was first identified by Callahan et al. in 1996 as an active impurity in the herbicide trifluralin, which […]

Domenico D’Ugo, ESSO 40: Hot Topics, What to Expect and Why Should HCPs Register

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jul 22nd 2021

touchONCOLOGY were delighted to speak with Professor Domenico D’Ugo, President of the European Society of Surgical Oncology (ESSO) one our media partners. He discusses why healthcare professionals should register and attend the ESSO 40 conference in November 2021 in Lisbon and what we can look forward to.

Questions
1. What can we expect from ESSO 40, the 40th Congress of the European Society of Surgical Oncology? (00:16-01:36)
2. Why should healthcare professionals attend the annual meeting in November? (01:36-02:55)
3. What presentations and data are you most looking forward to? (02:55-04:09)
4. What are the current most exciting advances in surgical oncology? (04:09-05:18)

Disclosure: Professor D’Ugo has no financial or non-financial conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Sophie Nickelson.

Filmed in coverage of the 2021 ESSO 40 Annual Meeting.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup